Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology.
about
Clinical experimentation with aerosol antibiotics: current and future methods of administration.Safety and efficacy of suicide gene therapy with adenosine deaminase 5-fluorocytosine silmutaneously in in vitro cultures of melanoma and retinal cell lines.Intensive care unit and lung cancer: when should we intubate?Enhancement of Intratumoral Chemotherapy with Cisplatin with or without Microwave Ablation and Lipiodol. Future Concept for Local Treatment in Lung Cancer.DDMC-p53 gene therapy with or without cisplatin and microwave ablation.Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.Suicide Gene Therapy for Cancer - Current Strategies.Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis.Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with 2-diethylaminoethyl-dextran methyl methacrylate copolymer non-viral vector-p53.Loco-regional administration of nanomedicines for the treatment of lung cancer.Enhancement of Aerosol Cisplatin Chemotherapy with Gene Therapy Expressing ABC10 protein in Respiratory System.Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab.Activation of proteinase-activated receptor 2 prevents apoptosis of lung cancer cells.Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment.Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol.Experimentation with aerosol bonsetan, pirfenidone, treprostinil and sidenafil.
P2860
Q30448377-A05A217E-8CBF-43E0-B12B-1F161B50BA19Q33556564-01BAC1A1-2526-4DBC-9DEA-EA680B290EF9Q34376000-DFAEC292-CB7C-4E79-9D15-A9E80819D979Q35051258-97856F74-8DE1-4B09-9DAB-F866AEF39312Q35654976-43163E8F-F8BE-48DC-AB86-A139B3BE876DQ37033793-1BE1B912-4701-4F71-B851-ECFD9B089277Q37347017-0DC979C2-B22D-43CB-ADED-EF88D336211BQ37495852-479444AB-635F-4698-9EE5-A82F4387CB0EQ38451785-40DE2EB0-C8A7-45B5-8CDB-DA2F2104F3E7Q38639228-4B987314-0154-469C-A7F9-F9F954CD4CE7Q38689201-BFF2ABE9-7015-452C-90E1-B5C5B5C7737BQ38955008-7768DA18-7E3E-47BF-A7F5-61F93441AB43Q39077024-3416DCA6-CFAA-4C82-B09B-A13166AAAFF5Q39109514-D7BD287E-F46D-4A40-BF1A-26EE543BBAE3Q42019910-057A01E8-68D9-446B-897A-82969B3E6F7DQ42084867-4D00F4D9-25D6-42E3-9693-544AB333383C
P2860
Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Efficacy versus safety concern ...... re dilemma for micro-oncology.
@en
type
label
Efficacy versus safety concern ...... re dilemma for micro-oncology.
@en
prefLabel
Efficacy versus safety concern ...... re dilemma for micro-oncology.
@en
P2093
P2860
P356
P1433
P1476
Efficacy versus safety concern ...... re dilemma for micro-oncology.
@en
P2093
Ekaterini Chatzaki
Kaid Darwiche
Kalliopi Domvri
Konstantinos Zarogoulidis
Nikos K Karamanos
Paul Zarogoulidis
Stylianos Kakolyris
Theodoros C Constantinidis
P2860
P304
P356
10.2217/FON.12.205
P407
P577
2013-04-01T00:00:00Z